Literature DB >> 20152225

Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation.

Michael V Orlov1, Julius M Gardin, Mara Slawsky, Renee L Bess, Gerald Cohen, William Bailey, Vance Plumb, Horst Flathmann, Katerina de Metz.   

Abstract

BACKGROUND: Randomized trials have demonstrated benefits of biventricular (BiV) pacing in patients with advanced heart failure, intraventricular conduction delay, and atrial fibrillation (AF) post-atrioventricular (AV) node ablation. The AV Node Ablation with CLS and CRT Pacing Therapies for Treatment of AF trial (AVAIL CLS/CRT) was designed to demonstrate superiority of BiV pacing in patients with AF after AV node ablation, to evaluate its effects on cardiac structure and function, and to investigate additional benefits of Closed Loop Stimulation (CLS) (BIOTRONIK, Berlin, Germany).
METHODS: Patients with refractory AF underwent AV node ablation and were randomized (2:2:1) to BiV pacing with CLS, BiV pacing with accelerometer, or right ventricular (RV) pacing. Echocardiography was performed at baseline and 6 months, with paired data available for 108 patients.
RESULTS: The RV pacing contributed to significant increase in left atrial volume, left ventricular (LV) end-systolic volume, and LV mass compared to BiV pacing. Ejection fraction decreased insignificantly with RV pacing compared to significant increase with BiV pacing. Interventricular dyssynchrony significantly decreased with BiV compared with RV pacing. Closed Loop Stimulation did not result in additional echocardiographic changes; heart rate distribution was significantly wider with CLS. All groups showed significant improvement in 6-minute walk distance, quality-of-life score, and New York Heart Association class.
CONCLUSION: In conclusion, RV pacing results in significant increase in left atrial volume, LV mass, and worsening of LV contractility compared to patients receiving BiV pacing post-AV node ablation for refractory AF. Closed Loop Stimulation was not associated with additional structural changes but resulted in significantly wider heart rate distribution. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20152225     DOI: 10.1016/j.ahj.2009.11.012

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  25 in total

Review 1.  Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome.

Authors:  Jason C Rubenstein; James A Roth
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

2.  Compensatory caspase activation in MPP+-induced cell death in dopaminergic neurons.

Authors:  J L Y Chee; X L Guan; J Y Lee; B Dong; S M Leong; E H Ong; A K F Liou; T M Lim
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

Review 3.  The importance of avoiding unnecessary right ventricular pacing in clinical practice.

Authors:  Finn Akerström; Miguel A Arias; Marta Pachón; Jesús Jiménez-López; Alberto Puchol; Justo Juliá-Calvo
Journal:  World J Cardiol       Date:  2013-11-26

4.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

Review 5.  Cardiac resynchronization therapy improves left ventricular remodeling and function compared with right ventricular pacing in patients with atrioventricular block.

Authors:  Dasheng Lu; Hao Zhang; Hongxiang Zhang
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

6.  Overdrive ventricular pacing in pacemaker recipients with permanent atrial fibrillation and sleep apnea.

Authors:  Philippe Bordier; Sylvie Maurice-Tison; Nishi Krishna Ramana
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

Review 7.  Exploring the Potential Role of Catheter Ablation in Patients with Asymptomatic Atrial Fibrillation: Should We Move away from Symptom Relief?

Authors:  Giovanni B Forleo; Luigi Di Biase; Domenico G Della Rocca; Gaetano Fassini; Luca Santini; Andrea Natale; Claudio Tondo
Journal:  J Atr Fibrillation       Date:  2013-10-31

Review 8.  Atrial Fibrillation and Heart Failure: A Review of the Intersection of Two Cardiac Epidemics.

Authors:  Kay Lee Park; Elad Anter
Journal:  J Atr Fibrillation       Date:  2013-06-30

9.  Expanding indications for resynchronization therapy.

Authors:  Christophe Leclercq; Nathalie Behar; Philippe Mabo; Jean-Claude Daubert
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 10.  [Current state of treatment strategies for atrial fibrillation].

Authors:  C Rogge; S Hilbert; N Dagres; G Hindricks
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.